EMA Says Possible Shortage of Genzyme’s Thyrogen Medicine

The European Medicines Agency said it was informed by Genzyme Corp. (GENZ) of a possible supply shortage of Thyrogen due to a manufacturing issue, according to an e- mailed statement from the agency.

To contact the editor responsible for this story: Kristen Hallam at khallam@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.